SCHEMBL4792534

SCHEMBL4792534

CC=CC(=O)Nc1cc2ccccc2[nH]1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIK1 P39086 1/20 0.46
DRD2 P14416 1/20 0.44
FLT3 P36888 1/20 0.44
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
LMNA P02545 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
KDM4E B2RXH2 2/20 0.42
MAPT P10636 1/20 0.42
DAO P14920 1/20 0.42
HPGD P15428 1/20 0.42
SRD5A2 P31213 1/20 0.42
HSD17B10 Q99714 1/20 0.42
ALDH1A1 P00352 1/20 0.42
GAA P10253 1/20 0.42
MAPK1 P28482 1/20 0.42
AHR P35869 1/20 0.41
ABCC9 O60706 1/20 0.41
ABCC8 Q09428 1/20 0.41
KCNJ11 Q14654 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5305682 0.83 GRIK1 (0.49) GRIK1DRD2FLT3NPC1RAB9A
SCHEMBL13134189 0.81 GRIK1 (0.48) GRIK1DRD2FLT3NPC1RAB9A
SCHEMBL31487774 0.79 MTNR1A (0.53) GRIK1DRD2FLT3NPC1RAB9A
SCHEMBL4413986 0.79 MTNR1A (0.53) GRIK1DRD2FLT3NPC1RAB9A
SCHEMBL9269321 0.77 GRIK1 (0.56) GRIK1DRD2FLT3NPC1RAB9A
SCHEMBL4195099 0.76 NPC1 (0.49) GRIK1DRD2FLT3NPC1RAB9A
SCHEMBL29493370 0.76 NPC1 (0.49) GRIK1DRD2FLT3NPC1RAB9A
SCHEMBL5515054 0.76 GRIK1 (0.51) GRIK1DRD2FLT3NPC1RAB9A
SCHEMBL5493171 0.76 KDM4E (0.51) GRIK1DRD2FLT3NPC1RAB9A
SCHEMBL4410319 0.75 DRD2 (0.49) GRIK1DRD2FLT3NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1973902-A2 3-HETEROCYCLYLACRYLAMIDE COMPOUNDS AS FABI INHIBITORS AND ANTIBACTERIAL AGENTS Affinium Pharmaceuticals, Inc. (CA) 2008-10-01 EP claimed
WO-2007067416-A2 HETEROCYCLYLACRYLAMIDE COMPOUNDS AS FABI INHIBITORS AND ANTIBACTERIAL AGENTS AFFINIUM PHARMACEUTICALS, INC. (CA) 2007-06-14 WO claimed